Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001562230-25-000032
Filing Date
2025-02-14
Accepted
2025-02-14 13:32:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5638
  Complete submission text file 0001562230-25-000032.txt   7525
Mailing Address 2340-2348 WALSH AVENUE, SUITE 2344 SANTA CLARA CA 95051
Business Address 2340-2348 WALSH AVENUE, SUITE 2344 SANTA CLARA CA 95051 408-627-4557
Semler Scientific, Inc. (Subject) CIK: 0001554859 (see all company filings)

EIN.: 261367393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88028 | Film No.: 25626228
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital International Investors (Filed by) CIK: 0001562230 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G